GlobeNewswire

CONDITIONS FOR RIKSBANK BID PROCEDURES SEK GOVERNMENT BONDS

Share

Sveriges Riksbank

Bid procedure details Government Bonds, 2020-06-12

Maturity dateLoanISIN codeCouponVolume, SEK million
2026-11-121059
SE00071259271.00 %1,000 +/- 250
2031-05-12
1062
SE00139353190.125 %1,000 +/- 250

Settlement date 2020-06-16

Bids have to be entered by 10.00 on JUN 12, 2020

Highest permitted bid volume: 1 000 SEK million in issue SGB 1059 and 1 000 SEK million in issue SGB 1062

Lowest permitted bid volume: 50 SEK million

Bids only through counterparties approved by the Riksbank

RESULT OF AUCTION WILL BE PUBLISHED NO LATER THAN 10.10 (CEST) ON JUN 12, 2020.


For more information, please contact:

Trading desk at the Riksbank

+ 46 8 696 6970

General and special terms and conditions can be retrieved athttp://www.riksbank.se

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

CellaVision AB presenterar andra kvartalet för 20207.7.2020 08:20:00 CESTPressemelding

CellaVision presenterar andra kvartalet för 2020 den 16 juli kl. 11:00 Informationen lämnades för offentliggörande 2020-07-07 kl 08.20 Den 16 juli 2020 klockan 08:20 publicerar CellaVision AB (publ) delårsrapporten för andra kvartalet. Rapporten kommer att finnas tillgänglig på www.cellavision.se I samband med detta inbjuds analytiker, investerare och media till en audiosänd telefonkonferens samma dag kl 11:00 där VD och koncernchef, Zlatko Rihter, presenterar och kommenterar rapporten. Presentationen sker på engelska via en telefonkonferens eller audiosändning på: https://tv.streamfabriken.com/cellavision-q2-2020 Telefonnummer till konferensen: SE: +46 8 566 42693 UK: +44 333 300 9267 US: +1 8 332 498 404 Ingen föranmälan krävs. Vänligen ring in till konferensen 5-10 minuter före utsatt starttid för att underlätta att den startar på fastställd tid. Om CellaVision CellaVision är ett innovativt, globalt medicinteknikföretag som utvecklar och säljer ledande system för rutinanalys av blod

CellaVision AB presents the second quarter for 20207.7.2020 08:20:00 CESTPress release

CellaVision presents the second quarter for 2020 on July 16, at 11:00 CET The information was submitted to the public on July 7, 2020 at 8:20 CET CellaVision AB (publ) will publish the Interim report for the second quarter 2020 on July 16, 2020 at 8:20 CET. The report will be available at www.cellavision.com In connection with the release of the interim report analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CET where Zlatko Rihter, President & CEO, will present and comment the report. The presentation will be in English via a conference call or audio webcast: https://tv.streamfabriken.com/cellavision-q2-2020 Phone number for the conference: SE: +46 8 566 42693 UK: +44 333 300 9267 US: +1 8 332 498 404 No pre-registration is required. Please dial in 5-10 minutes prior to the scheduled start time to facilitate a timely start. About CellaVision CellaVision is an innovative, global medical technology company that develops and sells its

Xavier Pichon appointed CEO of Orange Belgium7.7.2020 08:00:00 CESTPress release

Press release Brussels, July 7, 2020 Xavier Pichon appointed CEO of Orange Belgium The Board of Directors of Orange Belgium has decided to appoint Xavier Pichon to the position of CEO of Orange Belgium as from September 1st, 2020. Xavier Pichon has 20 years’ experience as an ExCom member in large corporations. He started his career in 1990 as Head of Finance of Bouygues’ affiliates, followed by an Audit & Consulting position at Calan Ramolino/Salustro Reydel before joining Orange in 1998 where he took up various positions, such as Chief Financial Officer of Orange France and Group Head of Investor Relations. His last role was Deputy CEO at Orange France, leading Finance, Strategy, Transformation and Development. There, he co-led one of the most successful transformations of an incumbent telco to date. He was President and Board member of different Orange affiliates. He joined the Boston Consulting Group (BCG) in October 2018 in Paris, then Sydney in Australia and was a core member of t

Ahold Delhaize share buyback update7.7.2020 08:00:00 CESTPress release

Zaandam, the Netherlands, July 7, 2020 – Ahold Delhaize has repurchased 250,000 of Ahold Delhaize common shares in the period from June 29, 2020 up to and including July 3, 2020. The shares were repurchased at an average price of €24.07 per share for a total consideration of € 6.02 million. These repurchases were made as part of the €1 billion share buyback program announced on December 4, 2019. The total number of shares repurchased under this program to date is 23,946,050 common shares for a total consideration of €520.9 million. Download the share buyback transactions excel sheet for detailed individual transaction information from www.aholddelhaize.com/en/investors/share-information/share-buy-back-programs/ This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation that contains technical standards for buyback programs

Novartis receives EC approval for Enerzair® Breezhaler®, including the first digital companion (sensor and app) that can be prescribed alongside a treatment for uncontrolled asthma in the EU7.7.2020 07:15:00 CESTPress release

European Commission approves once-daily Enerzair®Breezhaler® (QVM149; IND/GLY/MF) in the EU, the first-in-class LABA/LAMA/ICS fixed-dose combination for patients whose asthma is uncontrolled with LABA/ICS1* Optional digital companion with sensor and app that provide inhalation confirmation, medication reminders and access to objective data to better support therapeutic decisions also covered by EC approval Approval based on robust efficacy and safety data from the Phase III IRIDIUM study, in which once-daily EnerzairBreezhaler was superior to once-daily Atectura® Breezhaler® (IND/MF) in improving the lung function of patients whose asthma is uncontrolled with LABA/ICS standard-of-care treatment2 Asthma affects an estimated 358 million people worldwide and can cause a significant personal, health and financial burden when not adequately controlled3,4 Basel, July 7, 2020 — Novartis today announced that the European Commission (EC) has approved Enerzair® Breezhaler® (QVM149; indacaterol a

NACON: NACON CONNECT IS TOMORROW, 7 JULY AT 7PM CEST6.7.2020 20:37:04 CESTPress release

NACON CONNECT IS TOMORROW, 7 JULY AT 7PM CEST Paris (France), 6 July 2020 – NACON's first digital conference is being held tomorrow at 7PM CEST / 10AM PT on its official YouTube channel: Click here to watch NACON Connect: https://youtu.be/IL8k55zQ924 With 10 games showcased, including 4 unannounced, from a range of genres including racing, RPGs and roguelikes, this conference is essential viewing for all video game fans. NACON Check all NACON games and accessories on the new website nacongaming.com ------------------------------------------------------------------------------------------------------------------------------------------ About NACON NACON is a company of the BIGBEN Group founded in 2019 to optimize its know-how through strong synergies in the video game market. By bringing together its 8 development studios, the publishing of AA video games, the design and distribution of premium gaming devices, NACON focuses 20 years of expertise at the service of players. This new unifi